Affinage · Toxoplasma gondii

GRA12B

putative dense granule protein GRA12 · UniProt S8GJ92

Annotated
2026-09-08
20 papers in source corpus 10 papers cited in narrative 11 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

The GRA12 family comprises secreted dense granule proteins of Toxoplasma gondii that associate with the intravacuolar membranous nanotubular network (IVN) of the parasitophorous vacuole (PV) and, during chronic infection, redistribute to the developing cyst wall and cyst matrix (PMID:18840447, PMID:31619500, PMID:33883265). GRA12B, a GRA12-related paralog, mirrors this behavior: it co-localizes with dense granules in extracellular tachyzoites, with GRA2 and the IVN in the tachyzoite-stage PV, and with GRA2 in the cyst matrix and cyst wall of bradyzoites, being secreted by bradyzoites and incorporated into the developing cyst wall in patterns similar to GRA12 (PMID:33883265). Functionally, GRA12B acts in the bradyzoite/cyst compartment: its deletion increases tachyzoite replication rate and elevates chronic-stage cyst burdens in mice, but those cysts are not efficiently maintained in vivo and show reduced in vitro reactivation efficiency, implicating GRA12B in cyst maintenance and reactivation competence (PMID:33883265). Beyond these localization and cyst-stage phenotypes, no further molecular mechanism specific to GRA12B has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 2 steps
  1. 2021 Medium

    It was unknown whether the GRA12-related paralog GRA12B shared the localization behavior of GRA12; imaging established that GRA12B tracks the same dense-granule/IVN/cyst compartments, placing it within the same intravacuolar GRA machinery.

    Evidence Fluorescence co-localization with GRA2 and DBA staining across extracellular tachyzoites, tachyzoite PV, and bradyzoite cyst stages

    PMID:33883265

    Open questions at the time
    • No demonstration of direct physical interaction between GRA12B and GRA2 or the IVN
    • Whether GRA12B localization depends on GRA2, as shown for GRA12, was not tested
  2. 2021 Medium

    The in vivo role of GRA12B was undefined; deletion showed it restrains tachyzoite replication and, despite raising cyst numbers, is required for efficient cyst maintenance and reactivation, revealing a stage-specific function in chronic infection.

    Evidence Targeted gene deletion with tachyzoite replication measurement, in vivo mouse cyst-burden assays, and in vitro cyst reactivation assays

    PMID:33883265

    Open questions at the time
    • The molecular mechanism linking GRA12B to cyst maintenance and reactivation is unresolved
    • No biochemical activity or binding partner identified
    • Whether GRA12B contributes to acute-phase IFN-γ resistance like GRA12 was not addressed

Open questions

Synthesis pass · forward-looking unresolved questions
  • The biochemical activity of GRA12B and how it distinguishes functionally from GRA12 within the shared IVN/cyst compartment remain unknown.
  • No molecular activity assigned to GRA12B
  • No structural model or defined interaction partners beyond co-localization with GRA2
  • Mechanistic basis for cyst maintenance/reactivation defect uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
GRA2 (CO-LOCALIZATION)

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2008 GRA12 is a dense granule protein secreted into the parasitophorous vacuole (PV), where it associates with the intravacuolar membranous nanotubular network (IVN). It is secreted from the anterior pole soon after invasion, transits to the posterior invaginated pocket where the tubulovesicular network assembles, and ultimately resides throughout the vacuolar space in both soluble and membrane-associated forms. By affinity chromatography, GRA12 co-purifies with the GRA2-associated protein complex in parasite and PV soluble fractions, but this association is lost in the PV membranous fraction. GRA12 fails to localize at the parasite posterior end in the absence of GRA2. Immunofluorescence microscopy, immuno-electron microscopy, affinity chromatography (tagged GRA2 pulldown), analysis of GRA2-knockout parasites International journal for parasitology High 18840447
2019 Deletion of GRA12 (associated with the IVN) renders parasites avirulent in mice and abolishes establishment of chronic infection. In IFN-γ-activated macrophages, Δgra12 parasites resist coating of the PVM with host immunity-related GTPases (IRGs) similarly to wild-type, yet the PV ultimately succumbs to IFN-γ-activated innate immunity, revealing that GRA12 mediates resistance to IFN-γ through an IRG-coating-independent mechanism. Targeted gene deletion (Δgra12) in type I RH and type II Pru strains; mouse acute/chronic infection assays; IFN-γ-activated macrophage assays with IRG coating readout mBio High 31266861
2019 GRA12 and other IVN-associated GRA proteins dynamically relocalize during cyst development: early in differentiation GRA12 appears at the cyst periphery with cyst wall markers, then shifts to co-localize with GRA2 in prominent cyst matrix puncta, and finally (by day 10) relocalizes from the cyst wall to puncta in the cyst matrix. Deletion of intravacuolar-network GRAs, including GRA12, reduced the rate of accumulation of cyst wall proteins at the cyst periphery, indicating a role in cyst wall maturation. Live-cell immunofluorescence with DBA staining during in vitro differentiation; genetic deletion mutants analyzed by confocal microscopy mSphere High 31619500
2019 GRA12 deletion increases MHC-I antigen presentation of PV-localized parasite antigens in macrophages and/or dendritic cells, indicating that GRA12, as part of the IVN, actively suppresses MHC-I antigen presentation to reduce CD8+ T cell recognition of infected host cells. Genetic deletion of GRA12 in Toxoplasma; MHC-I antigen presentation assay with CD8+ T cell readout in macrophages and dendritic cells; comparison with other GRA/ROP deletion mutants Frontiers in immunology Medium 31555296
2020 Deletion of GRA12 in type I RH and type II Pru strains does not affect in vitro parasite growth or replication, but significantly reduces virulence and tissue cyst burden in vivo. Δgra12 mutants are more vulnerable to host immunity without accumulation of Irga6 on the PVM. The ultrastructure of the IVN in Δgra12 mutants appears normal, indicating GRA12 is not required for IVN biogenesis. Combined deletion of GRA12 and ROP18 causes more severe virulence attenuation than either single mutant, suggesting a functional interaction between GRA12 and ROP18. CRISPR-Cas9 gene deletion; in vitro growth assays; mouse virulence assays; immunofluorescence for Irga6 loading; electron microscopy of IVN ultrastructure; double-knockout epistasis analysis FASEB journal Medium 31908049
2021 GRA12B (a GRA12-related paralog) colocalizes with dense granules in extracellular tachyzoites, with GRA2 and the IVN in the tachyzoite-stage PV, and with GRA2 in the cyst matrix and cyst wall of bradyzoites. Deletion of GRA12B (Δgra12B) increases tachyzoite replication rate, increases chronic-stage cyst burdens in mice, but those Δgra12B cysts are not efficiently maintained in vivo. Additionally, Δgra12B in vitro cysts display a reduced reactivation efficiency. Targeted gene deletion; fluorescence localization assays (co-localization with GRA2, DBA staining); in vivo mouse infection assays for cyst burden; in vitro cyst reactivation assays; tachyzoite replication rate measurement mSphere Medium 33883265
2021 GRA12B is secreted by bradyzoites and incorporated into the developing cyst wall as well as the cyst matrix in distinct patterns, similar to GRA12 itself. Immunofluorescence localization assays during in vitro bradyzoite differentiation mSphere Medium 33883265
2023 In vivo CRISPR screens in C57BL/6 and Ifngr1−/− mice identified GRA12 as one of the most important IFN-γ-dependent virulence genes across Toxoplasma secretome effectors, confirming its role in parasite survival is dependent on the IFN-γ immune axis. Pooled in vivo CRISPR-Cas9 screen in immunocompetent and IFN-γ receptor-deficient mice Cell reports Medium 37269286
2025 Systematic pooled in vivo CRISPR-Cas9 screens targeting the Toxoplasma secretome across multiple parasite strains and mouse subspecies identified GRA12 as the most important effector protein for acute infection survival. Deletion of GRA12 in IFN-γ-activated macrophages results in collapsed parasitophorous vacuoles and increased host cell necrosis, which is partially rescued by inhibiting early parasite egress. GRA12 orthologues from Neospora caninum and Hammondia hammondi complement TgΔGRA12 in vitro, suggesting a conserved mechanism of protection from immune clearance. Pooled in vivo CRISPR-Cas9 screens; GRA12 deletion in IFN-γ-activated macrophages with PV morphology readout (collapsed PV); host cell necrosis assay; early egress inhibition rescue experiment; cross-species complementation with N. caninum and H. hammondi GRA12 orthologues Nature communications High 40240328
2026 GRA12 significantly inhibits NF-κB promoter activity and transcriptional expression of IL-6, IL-12, TNF-α, and IFN-β. Mechanistically, GRA12 suppresses activation of the IKK complex and p65, and prevents nuclear translocation of p65, thereby blocking the NF-κB signaling pathway. Plasmid transfection, luciferase reporter assay for NF-κB promoter activity, quantitative PCR for cytokine transcription, western blot for IKK complex and p65 phosphorylation/activation, nuclear translocation assay Genes Medium 42074593
2016 Deletion of the IVN-associated dense granule protein GRA12 in uracil auxotrophic T. gondii vaccine strains severely abrogates antitumor immunity, indicating that GRA12 function at the intravacuolar network is required for activating host antitumor responses through CD8α+ dendritic cells and the IL-12/IFN-γ TH1 axis. Targeted gene deletion in Δku80 uracil auxotrophic vaccine strain; mouse tumor model with immune cell depletion and cytokine readouts PLoS genetics Medium 27447180

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2019 Toxoplasma gondii Parasitophorous Vacuole Membrane-Associated Dense Granule Proteins Orchestrate Chronic Infection and GRA12 Underpins Resistance to Host Gamma Interferon. mBio 75 31266861
2008 GRA12, a Toxoplasma dense granule protein associated with the intravacuolar membranous nanotubular network. International journal for parasitology 50 18840447
2016 Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity. PLoS genetics 47 27447180
2020 Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 31908049
2023 Host genetics highlights IFN-γ-dependent Toxoplasma genes encoding secreted and non-secreted virulence factors in in vivo CRISPR screens. Cell reports 30 37269286
2018 Functional Characterization of Dense Granule Proteins in Toxoplasma gondii RH Strain Using CRISPR-Cas9 System. Frontiers in cellular and infection microbiology 30 30211128
2019 Toxoplasma gondii Intravacuolar-Network-Associated Dense Granule Proteins Regulate Maturation of the Cyst Matrix and Cyst Wall. mSphere 29 31619500
2021 Multi-epitope vaccine expressed in Leishmania tarentolae confers protective immunity to Toxoplasma gondii in BALB/c mice. Microbial pathogenesis 25 33933602
2019 Rhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells. Frontiers in immunology 21 31555296
2021 Comparative Proteomics Analysis for Elucidating the Interaction Between Host Cells and Toxoplasma gondii. Frontiers in cellular and infection microbiology 14 34055664
2021 A Family of Toxoplasma gondii Genes Related to GRA12 Regulate Cyst Burdens and Cyst Reactivation. mSphere 12 33883265
2020 Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii. Clinical and experimental vaccine research 11 32864364
2023 Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice. Frontiers in cellular and infection microbiology 9 37502604
2017 Toward detection of toxoplasmosis from urine in mice using hydro-gel nanoparticles concentration and parallel reaction monitoring mass spectrometry. Nanomedicine : nanotechnology, biology, and medicine 6 29203146
2025 Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats. Vaccines 4 40872935
2025 GRA12 is a common virulence factor across Toxoplasma gondii strains and mouse subspecies. Nature communications 3 40240328
2025 Bacillus subtilis spores displaying Toxoplasma gondii GRA12 induce immunity against acute toxoplasmosis. Frontiers in immunology 3 40079011
2025 GRA86 Is a Novel Dense Granule Protein Important for Virulence and Bradyzoite Differentiation in Toxoplasma gondii. Animals : an open access journal from MDPI 2 40941387
2022 Protective immunity induced with a DNA vaccine encoding B- and T-cells multi-epitope SAG1, ROP16, MIC4, GRA12, M2AP, and multi-epitope ROP8 against acute and chronic toxoplasmosis in BALB/c mice. Experimental parasitology 2 36162598
2026 Toxoplasma gondii GRA12 Inhibits the NF-ΚB Signaling Pathway by Targeting P65 and the IKK Complex. Genes 0 42074593